Gender disparity not found for alcohol use disorder’s link to suicide
March 18th 2024A recent study sheds light on the significant association between alcohol use disorder and suicide mortality found regardless of sex, emphasizing the importance of addressing alcohol use disorder in suicide prevention strategies.
Read More
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care
March 18th 2024Marlena S. Fejzo, PhD, sheds light on Harmonia Healthcare's innovative approach to tackling hyperemesis gravidarum, offering personalized care and telehealth options to address unmet patient needs and reduce emergency room visits.
Read More
Multicomponent intervention boosts quality of life in overactive bladder patients
March 15th 2024A recent study reveals the efficacy of a cognitive behavior therapy program, showcasing significant improvements in health-related quality of life among women grappling with moderate to severe overactive bladder.
Read More
NIH: Intervention mitigates postpartum depression and anxiety risks
March 15th 2024A recent study from the National Institutes of Health reveals an intervention led by non-specialist providers during pregnancy significantly lowers postpartum depression and anxiety risks, especially crucial for women in resource-poor settings where mental health care access is limited.
Read More
Optimizing pain management post urogynecologic surgery with restrictive opioid protocol
March 14th 2024A recent study suggests that restrictive opioid prescribing protocols post-urogynecologic surgery are as effective as standard protocols, emphasizing the importance of multimodal analgesia and outpatient follow-up for patient satisfaction.
Read More
Impact of serum estradiol decline before hCG-triggering on IVF outcomes
March 13th 2024A recent study delves into how serum estradiol decline preceding human chorionic gonadotropin administration affects in vitro fertilization outcomes, particularly among patients without oral contraceptive pretreatment, shedding light on the importance of monitoring during controlled ovarian hyperstimulation.
Read More
Dysmenorrhea management via telemedicine vs. in-person visits only
March 12th 2024Investigating dysmenorrhea outcomes with low-dose pill prescriptions reveals no significant difference between combination telemedicine and in-person consultations vs in-person only, prompting further exploration into telemedicine's role in gynecological care.
Read More
Study finds no increased stress urinary incontinence recurrence risk from childbirth
March 11th 2024A recent meta-analysis challenged common clinical assumptions, finding no increased risk of stress urinary incontinence recurrence or need for reoperation after subsequent pregnancy and childbirth following a midurethral sling procedure.
Read More
Lack of association found between vitamin D and miscarriage risk
March 8th 2024Investigating the relationship between 25-hydroxyvitamin D (25OHD) levels and miscarriage risk, a recent study utilizing mendelian randomization analysis found minimal causal association, suggesting no significant impact of vitamin D deficiency on miscarriage risk.
Read More
Study finds no link between prenatal antiseizure medication exposure and child epilepsy risk
March 8th 2024Recent research suggested that despite concerns about valproate use during pregnancy, prenatal exposure to antiseizure medications does not appear to raise the risk of epilepsy in offspring.
Read More
Fish and omega-3 supplement intake found lacking in pregnant women
March 8th 2024A recent study highlighted the disparity between dietary recommendations and actual intake of fish and omega-3 supplements among pregnant women, underscoring the need for targeted public health interventions to address this shortfall.
Read More
NIH study finds long-acting ART safe for HIV suppression in adolescents
March 7th 2024Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that long-acting injectable antiretroviral therapy provides improved HIV suppression with minimal adverse effects, offering a promising alternative for adolescents and individuals struggling with daily oral regimens.
Read More
HIV remission among children reported over 1 year after treatment interruption
March 7th 2024Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that 4 children, treated with antiretroviral therapy within 48 hours of birth, have achieved over a year of HIV remission.
Read More
Evaluating GeneXpert point-of-care testing for STIs
March 6th 2024A recent study assessed the effectiveness of GeneXpert point-of-care testing in detecting chlamydia, gonorrhoea, and trichomonas, revealing promising results but highlighting concerns over sensitivity rates, particularly for trichomonas.
Read More
Dapivirine ring and oral PrEP found safe for preventing HIV in pregnant women
March 6th 2024Recent findings affirm the safety of monthly dapivirine vaginal rings and daily oral PrEP with tenofovir disoproxil fumarate and emtricitabine in preventing HIV transmission among pregnant cisgender women.
Read More
Study finds AI tool MySTIRisk effectively identifies high-risk STI subgroups
March 5th 2024A recent study revealed the effectiveness of the AI tool MySTIRisk in pinpointing high-risk subgroups for HIV and other sexually transmitted infections, shedding light on improved risk assessment and testing accessibility.
Read More
Dexamethasone dosage in preterm births: Efficacy found from 5-mg dose
March 5th 2024A recent study compared the efficacy and safety of 5-mg versus 6-mg doses of dexamethasone in preventing neonatal respiratory distress syndrome in preterm births, shedding light on dosage optimization for improved neonatal outcomes.
Read More
Risk of graft loss in pregnant kidney transplant recipients
March 5th 2024A study examines the association between donor types and obstetrical and graft morbidity risks among pregnant kidney transplant recipients, revealing increased short- and long-term graft loss risk from pregnancy after deceased donor kidney transplant compared to living donor kidney transplant.
Read More
Study: Amniocentesis doesn't increase hepatitis B transmission risk in infants
March 4th 2024A recent study finds that, contrary to previous concerns, amniocentesis does not heighten the risk of mother-to-child transmission of hepatitis B virus among infants following a standardized immunoprophylaxis schedule.
Read More